Mandeep Singh Sehmbey, MD
Family Practice · Yuba City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
Hospitals listed: Sutter Medical Center, Sacramento. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Sehmbey’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A115828 · Current
Licensed to practise in California · since 2011 · expires 2028-12-31 · Pennsylvania State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$110,114
Medicare paid this office $110,114 for 954 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 494 | $52,233 | $95 |
| Short return visit (20+ min) | 361 | $26,474 | $66 |
| Long return visit (40+ min) | 69 | $9,435 | $137 |
| New patient visit (45+ min) | 68 | $7,264 | $107 |
| New patient visit (30+ min) | 38 | $2,687 | $71 |
See all 15 services
| Return visit (30+ min) | 494 | $52,233 | $95 |
| Short return visit (20+ min) | 361 | $26,474 | $66 |
| Long return visit (40+ min) | 69 | $9,435 | $137 |
| New patient visit (45+ min) | 68 | $7,264 | $107 |
| New patient visit (30+ min) | 38 | $2,687 | $71 |
| New patient visit (60+ min) | 12 | $1,591 | $133 |
| Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) | 40 | $1,180 | $30 |
| Injection of drug or substance under skin or into muscle | 91 | $1,153 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 89 | $1,055 | $12 |
| Administration of vaccine | 40 | $670 | $17 |
| Urinalysis, manual test | 178 | $629 | $3 |
| Detection test by immunoassay technique for streptococcus, group a (strep) | 27 | $445 | $16 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 44 | $148 | None |
| Injection, ceftriaxone sodium, per 250 mg | 52 | $81 | None |
| Automated urinalysis test | 11 | $24 | $2 |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
954 Original Medicare patients in 2024. Average age 74 · Under 65 9% · 85 and older 14% · Women 63% · Also on Medicaid 20% · Health risk score 1.17. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 36% · Coronary heart disease 29% · Chronic kidney disease 28% · Depression 21% · COPD 20% · Heart failure 18% · Atrial fibrillation 18% · Cancer 14% · Stroke 7% · Dementia 5%.
The office billed $445,209, Medicare allowed $152,141 and paid $110,114; for 2,294 services of 46 kinds; $1,512 of it was for drugs given in the office and $108,602 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 954 | 2,294 | 74 | 1.17 | $445,209 | $110,114 |
| 2022 | 559 | 941 | 74 | 1.15 | $512,491 | $69,763 |
| 2021 | 358 | 699 | 72 | 1.41 | $294,978 | $42,942 |
| 2020 | 310 | 672 | 71 | 1.56 | $203,522 | $32,174 |
| 2019 | 246 | 408 | 74 | 1.18 | $76,960 | $19,339 |
| 2018 | 337 | 578 | 73 | 1.15 | $69,425 | $30,223 |
| 2017 | 47 | 98 | 71 | 1.62 | $7,515 | $3,225 |
| 2016 | 37 | 76 | 71 | 1.55 | $6,506 | $2,746 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 11 services
| Return visit (30+ min) | 276 | $34,537 | $115 |
| Short return visit (20+ min) | 190 | $16,095 | $80 |
| New patient visit (45+ min) | 54 | $7,129 | $132 |
| Long return visit (40+ min) | 28 | $4,109 | $147 |
| New patient visit (30+ min) | 40 | $3,434 | $86 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 48 | $564 | $12 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 30 | $490 | $16 |
| Urinalysis, manual test | 89 | $333 | $3 |
| Removal of impacted ear wax by washing | 16 | $248 | $14 |
| Injection of drug or substance under skin or into muscle | 12 | $142 | $12 |
| Blood glucose (sugar) level | 13 | $50 | $4 |
2021: 12 services
| Return visit (30+ min) | 141 | $16,994 | $116 |
| Short return visit (20+ min) | 173 | $15,739 | $81 |
| New patient visit (45+ min) | 18 | $2,778 | $154 |
| Long return visit (40+ min) | 14 | $2,435 | $162 |
| New patient visit (30+ min) | 14 | $1,364 | $97 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $426 | $35 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 24 | $397 | $17 |
| Urinalysis, manual test | 80 | $296 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 39 | $261 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $229 | $13 |
| Injection of drug or substance under skin or into muscle | 16 | $207 | $11 |
| Blood glucose (sugar) level | 16 | $67 | $4 |
2020: 9 services
| Return visit (30+ min) | 178 | $18,530 | $88 |
| Short return visit (20+ min) | 121 | $9,011 | $64 |
| Telephone medical discussion with physician, 5-10 minutes | 26 | $930 | $36 |
| Injection of drug or substance under skin or into muscle | 22 | $323 | $13 |
| Detection test by immunoassay with direct visual observation for influenza virus | 17 | $300 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 38 | $294 | $8 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 13 | $211 | $16 |
| Urinalysis, manual test | 47 | $183 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $20 | None |
2019: 8 services
| Return visit (30+ min) | 100 | $7,951 | $78 |
| Short return visit (20+ min) | 75 | $4,425 | $56 |
| New patient visit (30+ min) | 40 | $2,861 | $72 |
| New patient visit (15+ min) | 22 | $1,144 | $52 |
| Detection test by immunoassay with direct visual observation for influenza virus | 15 | $406 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $137 | $11 |
| Urinalysis, manual test | 33 | $113 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 11 | $87 | $8 |
2018: 12 services
| Return visit (30+ min) | 143 | $12,592 | $87 |
| New patient visit (30+ min) | 65 | $5,500 | $85 |
| Short return visit (20+ min) | 82 | $5,362 | $62 |
| New patient visit (45+ min) | 17 | $2,224 | $131 |
| New patient visit (15+ min) | 22 | $1,278 | $58 |
| Short return visit | 11 | $415 | $38 |
| Injection of drug or substance under skin or into muscle | 20 | $305 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $263 | $13 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 13 | $211 | $16 |
| Urinalysis, manual test | 47 | $160 | $3 |
| Insertion of needle into vein for collection of blood sample | 15 | $47 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $16 | None |
2017: 1 service
| Short return visit (20+ min) | 34 | $1,967 | $55 |
2016: 1 service
| Short return visit (20+ min) | 21 | $1,095 | $52 |
Medicaid work
$385 in 2024
Medicaid paid $385 for 50 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 28 | $248 |
| Short return visit (20+ min) | 22 | $137 |
| 2024 | 50 | 2 | 18 | $385 |
Drugs they prescribed that Part D paid
$25,285
Pharmacies billed $25,285 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (15 of 872) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
792 generic and fewer than 11 brand-name prescriptions · $25,285 in drug cost · 428 antibiotic prescriptions to 351 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Breo Ellipta | 26 | $9,806 | $377 |
| Ciprofloxacin-Dexamethasone | 18 | $1,722 | $96 |
| Amoxicillin-Clavulanate Potass | 161 | $1,156 | $7 |
| Cephalexin | 116 | $478 | $4 |
| Doxycycline Hyclate | 67 | $476 | $7 |
See all 14 drugs
| Breo Ellipta | 26 | $9,806 | $377 |
| Ciprofloxacin-Dexamethasone | 18 | $1,722 | $96 |
| Amoxicillin-Clavulanate Potass | 161 | $1,156 | $7 |
| Cephalexin | 116 | $478 | $4 |
| Doxycycline Hyclate | 67 | $476 | $7 |
| Cefdinir | 17 | $373 | $22 |
| Methylprednisolone | 82 | $318 | $4 |
| Ciprofloxacin | 30 | $220 | $7 |
| Mupirocin | 18 | $127 | $7 |
| Prednisone | 79 | $120 | $2 |
| Fluconazole | 11 | $49 | $4 |
| Meloxicam | 11 | $36 | $3 |
| Amoxicillin | 13 | $27 | $2 |
| Paxlovid | 14 | $0 | $0 |
Year by year
| 2024 | 872 | 534 | 2% (15) | None | $25,285 |
| 2023 | 31 | 12 | 0% (0) | 0% | $465 |
| 2022 | 747 | 452 | 2% (11) | 13% | $34,559 |
| 2021 | 324 | 213 | None | 12% | $13,285 |
| 2020 | 287 | 175 | None | 12% | $12,914 |
| 2019 | 253 | 157 | None | 23% | $16,053 |
| 2018 | 290 | 205 | 5% (15) | 14% | $11,933 |
| 2017 | 141 | 93 | 15% (21) | 18% | $6,902 |
| 2016 | 533 | 321 | 15% (81) | 14% | $13,781 |
| 2015 | 546 | 257 | 9% (51) | None | $26,850 |
| 2014 | 224 | 40 | None | None | $11,950 |
| 2013 | 100 | 28 | None | None | $4,285 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 15 drugs
| Breo Ellipta | 50 | $19,864 | $397 |
| Amoxicillin-Clavulanate Potass | 103 | $1,062 | $10 |
| Cephalexin | 82 | $420 | $5 |
| Doxycycline Hyclate | 23 | $409 | $18 |
| Methylprednisolone | 44 | $320 | $7 |
| Lactulose | 13 | $254 | $20 |
| Paxlovid (Eua) | 20 | $208 | $10 |
| Nitrofurantoin Mono-Macro | 14 | $201 | $14 |
| Mupirocin | 22 | $182 | $8 |
| Prednisone | 72 | $142 | $2 |
| Erythromycin | 12 | $139 | $12 |
| Ciprofloxacin | 21 | $137 | $7 |
| Hydrocortisone | 12 | $91 | $8 |
| Sulfamethoxazole-Trimethoprim | 15 | $66 | $4 |
| Amoxicillin | 11 | $19 | $2 |
2021: 8 drugs
| Diclofenac | 14 | $384 | $27 |
| Nitrofurantoin Mono-Macro | 15 | $276 | $18 |
| Amoxicillin-Clavulanate Potass | 25 | $260 | $10 |
| Methylprednisolone | 25 | $219 | $9 |
| Cephalexin | 44 | $177 | $4 |
| Mupirocin | 12 | $67 | $6 |
| Prednisone | 38 | $63 | $2 |
| Ciprofloxacin | 11 | $61 | $6 |
2020: 6 drugs
| Breo Ellipta | 18 | $6,504 | $361 |
| Amoxicillin-Clavulanate Potass | 26 | $298 | $11 |
| Doxycycline Hyclate | 15 | $228 | $15 |
| Methylprednisolone | 24 | $191 | $8 |
| Cephalexin | 28 | $88 | $3 |
| Prednisone | 28 | $77 | $3 |
2019: 6 drugs
| Breo Ellipta | 28 | $9,911 | $354 |
| Doxycycline Hyclate | 32 | $816 | $26 |
| Amoxicillin-Clavulanate Potass | 27 | $327 | $12 |
| Methylprednisolone | 25 | $315 | $13 |
| Cephalexin | 25 | $162 | $6 |
| Prednisone | 16 | $23 | $1 |
2018: 7 drugs
| Breo Ellipta | 11 | $3,821 | $347 |
| Doxycycline Hyclate | 28 | $786 | $28 |
| Methylprednisolone | 37 | $424 | $11 |
| Amoxicillin-Clavulanate Potass | 28 | $299 | $11 |
| Cephalexin | 34 | $157 | $5 |
| Acetaminophen-Codeine | 13 | $46 | $4 |
| Prednisone | 20 | $45 | $2 |
2017: 2 drugs
| Doxycycline Hyclate | 12 | $238 | $20 |
| Cephalexin | 13 | $60 | $5 |
2016: 13 drugs
| Qvar | 12 | $1,366 | $114 |
| Proair Hfa | 25 | $954 | $38 |
| Methylprednisolone | 23 | $714 | $31 |
| Tamsulosin | 11 | $615 | $56 |
| Amoxicillin-Clavulanate Potass | 26 | $459 | $18 |
| Hydrocodone-Acetaminophen | 28 | $415 | $15 |
| Prednisone | 26 | $403 | $15 |
| Tramadol | 45 | $388 | $9 |
| Fluticasone Propionate | 26 | $345 | $13 |
| Cephalexin | 34 | $337 | $10 |
| Ciprofloxacin | 22 | $247 | $11 |
| Famotidine | 14 | $169 | $12 |
| Meloxicam | 27 | $149 | $6 |
2015: 17 drugs
| Proair Hfa | 24 | $1,514 | $63 |
| Fluticasone Propionate | 32 | $678 | $21 |
| Clindamycin | 21 | $494 | $24 |
| Hydrocodone-Acetaminophen | 28 | $472 | $17 |
| Omeprazole | 11 | $337 | $31 |
| Cephalexin | 25 | $337 | $13 |
| Doxycycline Monohydrate | 18 | $331 | $18 |
| Amoxicillin-Clavulanate Potass | 13 | $266 | $20 |
| Ciprofloxacin | 17 | $264 | $16 |
| Prednisone | 14 | $213 | $15 |
| Metoprolol | 12 | $185 | $15 |
| Metformin | 16 | $173 | $11 |
| Tramadol | 15 | $140 | $9 |
| Gabapentin | 13 | $130 | $10 |
| Amlodipine Besylate | 17 | $130 | $8 |
| Meloxicam | 17 | $108 | $6 |
| Losartan | 11 | $77 | $7 |
2014: 7 drugs
| Gabapentin | 23 | $392 | $17 |
| Warfarin | 16 | $279 | $17 |
| Amlodipine Besylate | 21 | $174 | $8 |
| Omeprazole | 12 | $86 | $7 |
| Lisinopril | 15 | $73 | $5 |
| Metoprolol | 11 | $51 | $5 |
| Furosemide | 14 | $48 | $3 |
2013: 1 drug
| Metoprolol | 12 | $43 | $4 |
Professional record
- NPI
- 1225346026
- Licence
- CA A115828California A115828: Current · expires 2028-12-31
- Trained
- Pennsylvania State University College of Medicine, 2009
- Group
- Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- Po Box 255228, Sacramento, CA, 95865
- NPI first listed
- 2010-09-15
- NPI last updated
- 2024-02-16
- NPI record certified
- 2024-02-16
This is when the NPI record was last certified, not a medical board exam.